CNXU Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

11.320

Open

10.870

VWAP

10.91

Vol

70.21K

Mkt Cap

290.60M

Low

10.550

Amount

766.00K

EV/EBITDA(TTM)

Total Shares

26.76M

284.34M

EV/OCF(TTM)

P/S(TTM)

Conexeu Sciences Inc. is an early-stage medical technology company. The Company is focused on developing regenerative biomaterials that address significant needs in wound care, dentistry, and aesthetics. The Company is focused on providing physicians with device-based solutions for healing, restoring soft tissue, and improving patient outcomes across multiple clinical settings. Its core device candidate, CXU, is a temperature-responsive ECM scaffold formulation intended to transition in-situ to a gel-like extra cellular matrix (ECM) within approximately minutes (Ten-Minute Tissue). The Company operates and manages its business in one operating segment, which is developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics.

Events Timeline

(ET)

2026-06-22

13:30:00

Kardigan Raises $400M in Initial Public Offering

2026-06-15 (ET)

2026-06-15

11:30:00

SpaceX Raises $85.7B in IPO, Valuation Exceeds $2 Trillion

2026-06-15

09:30:00

Conexeu Sciences Appoints David Bogart as Chief Commercial Officer

2026-05-26 (ET)

2026-05-26

11:10:00

SpaceX Files for IPO Aiming to Raise $80 Billion

2026-05-21 (ET)

2026-05-21

11:50:00

Conexeu Sciences Expected to Begin Trading on Nasdaq on May 21

News

8.5

06-25Newsfilter

Conexeu Sciences Targets GLP-1 Aesthetics Market with Innovative Platform

8.5

06-25Newsfilter

Conexeu Opens New R&D Facility in Vancouver to Advance Tissue Regeneration

8.5

06-18Newsfilter

Regenerative Medicine Market Rapid Expansion

8.5

06-18Globenewswire

Rapid Expansion of the Regenerative Medicine Market

8.5

06-17NASDAQ.COM

CervoMed and Others See Significant Stock Gains

8.5

06-16Globenewswire

Conexeu Sciences Advances Wound Care Technology

0 Analyst Rating

Wall Street analysts forecast CNXU stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

H.C. Wainwright

initiated

$20

AI Analysis

2026-06-22

Reason

H.C. Wainwright

Price Target

$20

AI Analysis

2026-06-22

initiated

Reason

H.C. Wainwright initiated coverage of Conexeu Sciences with a Buy rating and $20 price target. Conexeu is a pre-commercial-stage regenerative medicine company, and its lead asset, CXU, is a \"differentiated,\" injectable collagen-based tissue-agnostic biomaterial with potential utility across a combined addressable market of $20B, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Conexeu Sciences Inc (CNXU.O) is 0.00, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Conexeu Sciences Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

Current PE

0.00

Overvalued PE

Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

Current PS

0.00

Overvalued PS

Undervalued PS

Financials

AI Analysis

Annual

Quarterly

Whales Holding CNXU

Trading Trends

People Also Watch

Frequently Asked Questions

What is Conexeu Sciences Inc (CNXU) stock price today?

The current price of CNXU is 10.86 USD — it has increased 5.85

What is Conexeu Sciences Inc (CNXU)'s business?

What is the price predicton of CNXU Stock?

Wall Street analysts forecast CNXU stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNXU is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.